Serum tumor necrosis factor in patients with gastric cancer

Chew Wun Wu, Chin Wen Chi, Mao Chih Hsieh, Miao Fen Chao, Wing Yiu Lui, Fang Ku P'Eng

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We have measured serum TNF-α levels in 220 gastric cancer patients, 9 patients with gastric polyps or ulcers, 9 hepatitis B carriers and 85 normal controls. The results showed that no postitive TNF-α value ( > 10 pg/ml) was detected in Hepatitis B carriers and benign gastric lesions' patients and normal controls. In the cancer group, 17 out of 220 patients (7.7%) had positive-TNF-α values. The proportion of TNF-α positive was 6.8% in stage I disease, 6.5% in stage ll disease, 3.7% stage III, and 12.9% stage IV. No clinicopathologic factors were related to positive TNF-α value. TNF-α value was not an indenendent prognostic indicator. The role of TNF-α in gastric cancer remains obscures.

Original languageEnglish
Pages (from-to)1597-1599
Number of pages3
JournalAnticancer Research
Volume18
Issue number3 A
Publication statusPublished - May 1998

Fingerprint

Stomach Neoplasms
Tumor Necrosis Factor-alpha
Hepatitis B
Serum
Stomach
Polyps
Ulcer
Neoplasms

Keywords

  • Gastric cancer
  • TNF-α

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Wu, C. W., Chi, C. W., Hsieh, M. C., Chao, M. F., Lui, W. Y., & P'Eng, F. K. (1998). Serum tumor necrosis factor in patients with gastric cancer. Anticancer Research, 18(3 A), 1597-1599.

Serum tumor necrosis factor in patients with gastric cancer. / Wu, Chew Wun; Chi, Chin Wen; Hsieh, Mao Chih; Chao, Miao Fen; Lui, Wing Yiu; P'Eng, Fang Ku.

In: Anticancer Research, Vol. 18, No. 3 A, 05.1998, p. 1597-1599.

Research output: Contribution to journalArticle

Wu, CW, Chi, CW, Hsieh, MC, Chao, MF, Lui, WY & P'Eng, FK 1998, 'Serum tumor necrosis factor in patients with gastric cancer', Anticancer Research, vol. 18, no. 3 A, pp. 1597-1599.
Wu CW, Chi CW, Hsieh MC, Chao MF, Lui WY, P'Eng FK. Serum tumor necrosis factor in patients with gastric cancer. Anticancer Research. 1998 May;18(3 A):1597-1599.
Wu, Chew Wun ; Chi, Chin Wen ; Hsieh, Mao Chih ; Chao, Miao Fen ; Lui, Wing Yiu ; P'Eng, Fang Ku. / Serum tumor necrosis factor in patients with gastric cancer. In: Anticancer Research. 1998 ; Vol. 18, No. 3 A. pp. 1597-1599.
@article{733d856d0d3b4e998c3f5049e105ea3c,
title = "Serum tumor necrosis factor in patients with gastric cancer",
abstract = "We have measured serum TNF-α levels in 220 gastric cancer patients, 9 patients with gastric polyps or ulcers, 9 hepatitis B carriers and 85 normal controls. The results showed that no postitive TNF-α value ( > 10 pg/ml) was detected in Hepatitis B carriers and benign gastric lesions' patients and normal controls. In the cancer group, 17 out of 220 patients (7.7{\%}) had positive-TNF-α values. The proportion of TNF-α positive was 6.8{\%} in stage I disease, 6.5{\%} in stage ll disease, 3.7{\%} stage III, and 12.9{\%} stage IV. No clinicopathologic factors were related to positive TNF-α value. TNF-α value was not an indenendent prognostic indicator. The role of TNF-α in gastric cancer remains obscures.",
keywords = "Gastric cancer, TNF-α",
author = "Wu, {Chew Wun} and Chi, {Chin Wen} and Hsieh, {Mao Chih} and Chao, {Miao Fen} and Lui, {Wing Yiu} and P'Eng, {Fang Ku}",
year = "1998",
month = "5",
language = "English",
volume = "18",
pages = "1597--1599",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 A",

}

TY - JOUR

T1 - Serum tumor necrosis factor in patients with gastric cancer

AU - Wu, Chew Wun

AU - Chi, Chin Wen

AU - Hsieh, Mao Chih

AU - Chao, Miao Fen

AU - Lui, Wing Yiu

AU - P'Eng, Fang Ku

PY - 1998/5

Y1 - 1998/5

N2 - We have measured serum TNF-α levels in 220 gastric cancer patients, 9 patients with gastric polyps or ulcers, 9 hepatitis B carriers and 85 normal controls. The results showed that no postitive TNF-α value ( > 10 pg/ml) was detected in Hepatitis B carriers and benign gastric lesions' patients and normal controls. In the cancer group, 17 out of 220 patients (7.7%) had positive-TNF-α values. The proportion of TNF-α positive was 6.8% in stage I disease, 6.5% in stage ll disease, 3.7% stage III, and 12.9% stage IV. No clinicopathologic factors were related to positive TNF-α value. TNF-α value was not an indenendent prognostic indicator. The role of TNF-α in gastric cancer remains obscures.

AB - We have measured serum TNF-α levels in 220 gastric cancer patients, 9 patients with gastric polyps or ulcers, 9 hepatitis B carriers and 85 normal controls. The results showed that no postitive TNF-α value ( > 10 pg/ml) was detected in Hepatitis B carriers and benign gastric lesions' patients and normal controls. In the cancer group, 17 out of 220 patients (7.7%) had positive-TNF-α values. The proportion of TNF-α positive was 6.8% in stage I disease, 6.5% in stage ll disease, 3.7% stage III, and 12.9% stage IV. No clinicopathologic factors were related to positive TNF-α value. TNF-α value was not an indenendent prognostic indicator. The role of TNF-α in gastric cancer remains obscures.

KW - Gastric cancer

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=0031854673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031854673&partnerID=8YFLogxK

M3 - Article

C2 - 9673376

AN - SCOPUS:0031854673

VL - 18

SP - 1597

EP - 1599

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 A

ER -